Jean-François Le Bigot, Executive Chairman of Oncovita

Jean-François Le Bigot , Executive Chairman of Oncovita

Jean-François Le Bigot has long and extensive experience in drug development combined with the executive management of private companies through major growth cycles and Private Equity investments. He is the former President, CEO and shareholder of Citoxlab Group, one of the leading international non-clinical Contract Research Organizations (CRO). From 1987 to 2019, Jean-Francois Le Bigot transformed Centre International de la Toxicologie (CIT), a single site French non-clinical CRO with 120 staff, into the internationally recognized Citoxlab brand that includes today 8 research centers located in 5 countries and employs more than 1 500 people. After his PhD in Pharmacology and Biochemistry, Jean-Francois Le Bigot started his industrial career at Sandoz Laboratories (now Novartis) as Head of Experimental Biology and then Director of Pre-Clinical Development in France.